Kisspeptin-10 and hCG Together: What Is Known
Kisspeptin-10 and hCG taken together: what each one is, how each is regulated, and what is known about combining them.
Timing, interactions and safety
Evidence for the combination
- Animal study (stallions, donkeys, mules) giving kisspeptin-10, hCG and LH in separate groups and comparing testosterone responses. · PMID 28753433
- Rhesus monkey study giving kisspeptin-10 and hCG challenges to the same animals. Animal data only. · PMID 18834893
Side by side
Showing 8 of 11 fields where the two differ. PCAC vote, Jul 2026, WADA, Evidence strength are the same or both unknown.
| Field | Kisspeptin-10 | hCG |
|---|---|---|
| Class | GnRH stimulator | Gonadotropin |
| Also called | kiss | human chorionic gonadotropin |
| Category | Sexual & hormonal health | Other |
| FDA status | Not FDA approved · research chemical | FDA approved (prescription only) |
| PCAC vote, Jul 2026 | Not on the Jul 2026 agenda | Not on the Jul 2026 agenda |
| WADA | Prohibited by WADA (S2.2.1)Kisspeptin and its agonist analogues are named in S2.2.1 (testosterone-stimulating peptides in males). | Prohibited by WADA (S2.2.1)Chorionic gonadotrophin (hCG) is prohibited for male athletes (S2.2.1, testosterone-stimulating peptides). The list limits this class to males. |
| Anti-doping detection |
| None reportedanti-doping literature, as of 2 Oct 2026 |
| Half-life | mean elimination half-life 1.3-2.2 hourssubcutaneous (analog MVT-602) · Fertility and sterility 2024, PMID 37925096 | pooled half-life 5.8 daysinjection (urinary and recombinant hCG) · Clinical endocrinology 2024, PMID 38446525 |
| Evidence strength | Human RCT evidence, 4 of 4Strongest: European journal of endocrinology 2026, PMID 42549827 | Human RCT evidence, 4 of 4Strongest: Clinical endocrinology 2024, PMID 38446525 |
| Human studies we summarised | 14 human (10 randomized or controlled) of 18 summarised | 11 human (9 randomized or controlled) of 17 summarised |
| Typical study doses |
|
|
Two ways to raise testosterone, tested in animals side by side
A study in stallions, donkeys and mules gave kisspeptin-10, hCG and LH in separate groups and compared testosterone; this is equine data.[11]
Rhesus monkeys received kisspeptin-10 and hCG challenges in fed and fasting states, to test whether suppression of reproduction by food restriction reflects reduced responsiveness to kisspeptin drive.[12]
In the monkeys, kisspeptin-10 (50 microg) and hCG (50 IU) were separate intravenous boluses, not a joint treatment.[12]
Human data for each
In healthy men, subcutaneous kisspeptin-10 infusions dose-dependently increased LH, FSH and testosterone.[5]
In a randomized trial of hypogonadal men, hCG raised testosterone to a final mean of 5.17 nmol/L, with no significant difference among arms.[9]
Regulatory differences
Novarel's label states that hCG has not been demonstrated to be effective adjunctive therapy in the treatment of obesity.[13]
FDA lists kisspeptin-10 in its 503A safety-risk table, dated September 29, 2023.[14]
WADA names kisspeptin among testosterone-stimulating peptides for males.[1]
hCG in pregnancy
Novarel's label says hCG may cause fetal harm when administered to a pregnant woman.[13]
What the dataset search found
The dataset search for kisspeptin with hCG returned 5 PubMed records, and 2 are classed as animal studies that gave both separately.
Calculated from pubmed query (("human chorionic gonadotropin"[tiab] OR "chorionic gonadotropin"[tiab] OR "chorionic gonadotrophin"[tiab] OR hCG[tiab] OR choriogonadotropin[tiab]) NOT (pregnan*[tiab] OR trophoblast*[tiab] OR choriocarcinoma[tiab] OR "germ cell"[tiab] OR hydatidiform[tiab] OR "embryo transfer"[tiab] OR oocyte*[tiab] OR "in vitro fertilization"[tiab] OR IVF[tiab] OR "ovarian stimulation"[tiab] OR "ovulation induction"[tiab] OR "ovarian hyperstimulation"[tiab] OR equine[tiab] OR eCG[tiab] OR "pregnant mare"[tiab])) AND ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab]); search date 2026-10-02; records returned 5; records classed as study of the pair 2. Formula: Counts copied from the combinations dataset (web/src/data/combinations.json, key hcg__kisspeptin); no arithmetic applied.
Common questions
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2[Not Available].Biomedical chromatography : BMC · 2024PMID 38978171Accessed 2 Oct 2026
- 3Analysis and Characterization of Kisspeptin and Its Analogues in Serum and Urine Samples by Liquid Chromatography-High-Resolution Mass Spectrometry for Doping Control Purposes.Drug testing and analysis · 2026PMID 42057309Accessed 2 Oct 2026
- 4Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.Fertility and sterility · 2024PMID 37925096Accessed 2 Oct 2026
- 5Chronic subcutaneous kisspeptin-10 stimulates gonadotropin secretion for 12 days in healthy men.European journal of endocrinology · 2026PMID 42549827Accessed 2 Oct 2026
- 6Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.JAMA network open · 2022PMID 36287566Accessed 2 Oct 2026
- 7Single and multi-dose pharmacology of recombinant and urinary human chorionic gonadotrophin in men.Clinical endocrinology · 2024PMID 38446525Accessed 2 Oct 2026
- 8Effect of Combined Low Dose Human Gonadotropic Hormone, Follicle Stimulating Hormone, and Testosterone Therapy (LFT Regimen) Versus Conventional High Dose Human Gonadotropic Hormone and Follicle Stimulating Hormone on Spermatogenesis and Biomarkers in Men With Hypogonadotropic Hypogonadism.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2024PMID 39025301Accessed 2 Oct 2026
- 9Clomiphene citrate and human chorionic gonadotropin are both effective in restoring testosterone in hypogonadism: a short-course randomized study.BJU international · 2018PMID 29772111Accessed 2 Oct 2026
- 10PubMed search: (("human chorionic gonadotropin"[tiab] OR "chorionic gonadotropin"[tiab] OR "chorionic gonadotrophin"[tiab] OR hCG[tiab] OR choriogonadotropin[tiab]) NOT (pregnan*[tiab] OR trophoblast*[tiab] OR choriocarcinoma[tiab] OR "germ cell"[tiab] OR hydatidiform[tiab] OR "embryo transfer"[tiab] OR oocyte*[tiab] OR "in vitro fertilization"[tiab] OR IVF[tiab] OR "ovarian stimulation"[tiab] OR "ovulation induction"[tiab] OR "ovarian hyperstimulation"[tiab] OR equine[tiab] OR eCG[tiab] OR "pregnant mare"[tiab])) AND ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab])PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 11Effect of kisspeptin-10, LH and hCG on serum testosterone concentrations in stallions, donkeys and mules.Theriogenology · 2017PMID 28753433Accessed 2 Oct 2026
- 12Short-term fasting attenuates the response of the HPG axis to kisspeptin challenge in the adult male rhesus monkey (Macaca mulatta).Life sciences · 2008PMID 18834893Accessed 2 Oct 2026
- 13NOVAREL ® (chorionic gonadotropin) for injection, for intramuscular use Initial U.S. Approval: 1974FDA label, DailyMed · current labeldailymed.nlm.nih.govAccessed 2 Oct 2026
- 14Official web pageOfficial web page · web page
Found an error? Report a correction.